An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2–dominated inflammatory response
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
In schistosomiasis, chronic parasite egg-induced granuloma formation can lead to tissue destruction and fibrosis, which causes much of the morbidity and mortality associated with this disease. Here we show the importance of IL-13 in the pathogenesis of schistosomiasis, and demonstrate, perhaps for the first time, the therapeutic efficacy of an IL-13 inhibitor, sIL-13Ralpha2-Fc, in the control of hepatic fibrosis. T-helper type 2 (Th2) cytokines dominate the immune response in mice infected with Schistosoma mansoni, yet the specific contributions of IL-13 and IL-4 to the development of fibrosis were not previously investigated. Our studies demonstrate that both cytokines play redundant roles in granuloma formation, which explains the ability of IL-4-deficient mice to form granulomas around eggs. More importantly, however, these studies demonstrate that IL-13 is the dominant Th2-type cytokine regulating fibrosis. IL-13 stimulated collagen production in fibroblasts, and procollagen I and procollagen III mRNA expression was decreased in sIL-13Ralpha2-Fc-treated mice. Moreover, the reduction in fibrosis observed in IL-4-deficient mice was much less pronounced than that in sIL-13Ralpha2-Fc-treated animals. Fibrosis is a major pathological manifestation of a number of allergic, autoimmune, and infectious diseases. Thus, our findings provide evidence that IL-13 inhibitors may be of general therapeutic benefit in preventing damaging tissue fibrosis resulting from Th2-dominated inflammatory responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-11, a member of the IL-6/gp130 cytokine family, may be one such target as it was recently shown to integrate pro-fibrotic signals emanating from both pathways146–149”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617 · cited 2×
“IL-13 was also recently shown to play a central role in murine asthma (30, 31).”
BackgroundSelf-citationRequirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Self-citationZhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719 · cited 1×
“Indeed, the targeted pulmonary expression of IL-13 was shown to cause mucus cell metaplasia, airway fibrosis, and nonspecific airway hyperreactivity (43).”
BackgroundStat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628 · cited 1×
“In contrast to these observations, granuloma formation and the development of hepatic fibrosis was severely impaired in Stat6-deficient mice (10), which display a major defect in the production of several Th2-associated cytokines (39).”
ResultTwo Improved and Simplified Methods for the Spectrophotometric Determination of Hydroxyproline.
Bergman, I., & Loxley, R. (1963) · Analytical Chemistry · doi:10.1021/ac60205a053 · Cited by 1,525 · cited 1×
“Specifically, hepatic collagen was measured as hydroxyproline by the technique of Bergman and Loxley after hydrolysis of a 200-mg portion of liver in 5 mL of 6 N HCl at 110°C for 18 hours (35).”
MethodDisruption of the murine IL-4 gene blocks Th2 cytokine responses
Kopf, M., Gros, G. L., Bachmann, M., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,203 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundLe Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D., & Paul, W. E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.921 · Cited by 954 · cited 2×
“Whereas it is well known that IL-4 is the primary cytokine driving CD4+ Th2 cell development (15, 16), the role of IL-13 in the generation and maintenance of Th2-type responses remains controversial and may be influenced by both host genetics and the infectious disease model under study (24, 27, 29).”
BackgroundPearce, E. J., Caspar, P., Grzych, J. M., Lewis, F. A., & Sher, A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.159 · Cited by 765
Urban, J. F., Noben-Trauth, N., Donaldson, D. D., Madden, K. B., Morris, S. C., Collins, M., & Finkelman, F. D. (1998) · Immunity · doi:10.1016/s1074-7613(00)80477-x · Cited by 580
Self-citationGrzych, J. M., Pearce, E., Cheever, A., Caulada, Z. A., Caspar, P., Heiny, S., Lewis, F., & Sher, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1322 · Cited by 542
Self-citation
Cited by
Items 401–500 of 608
Kuete, J. B. T., Kuete, J. R. N., Mbaveng, A. T., Kuete, V., Efferth, T., & Weiskirchen, R. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157242 · Cited by 18
Kato‐Kogoe, N., Ohyama, H., Nishimura, F., Meguro, M., Yoshizawa, S., Okada, Y., Nakasho, K., Yamanegi, K., Yamada, N., Hata, M., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.128 · Cited by 18
Induction and Characterization of the Allergic Eye Disease Mouse Model
Reyes, N. S., Mathew, R., & Saban, D. R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7896-0_5 · Cited by 18
Maternal Infection with Schistosoma japonicum Induces a Profibrotic Response in Neonates
McDonald, E. A., Cheng, L., Jarilla, B. R., Sagliba, M. J., Gonzal, A., Amoylen, A. J., Olveda, R. M., Acosta, L. P., Baylink, D. J., White, E. S., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01060-13 · Cited by 18
Ochi, T., Kawakita, T., & Nomoto, K. (2004) · Immunopharmacology and Immunotoxicology · doi:10.1081/iph-120037726 · Cited by 18
“Indeed, knockout and cytokine ablation studies have clearly demonstrated an important role for Th2-type cytokines in granuloma formation, tissue eosinophilia, IgG1/IgE antibody production, and the development of hepatic fibrosis.([6,7]) Recent studies identified IL-13 receptors on hepatic fibroblasts, and exogenous IL…”
BackgroundBhattacharjee, S., Mejías‐Luque, R., Loffredo‐Verde, E., Toska, A., Floßdorf, M., Gerhard, M., & da Costa, C. P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.108 · Cited by 18
“IL-13dRa2 has thus been shown to not only be host protective but also prolong host survival during schistosomiasis (Chiaramonte et al., 1999; Mentink-Kane et al., 2004).”
BackgroundOsada, Y., Horie, Y., Nakae, S., Sudo, K., & Kanazawa, T. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13214 · Cited by 17
The link between immunity and hypertension in the kidney and heart
Benson, L. N., Guo, Y., Deck, K. S., Mora, C. J., Liu, Y., & Mu, S. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1129384 · Cited by 20
“TGF-β signals through the SMAD pathway inside of the homeostatic fibroblasts and induces the assembly of SMADs 2 and 3 into SMAD 4.”
BackgroundInfluentialRole of IL ‐4 R α during acute schistosomiasis in mice
Ndlovu, H., & Brombacher, F. (2013) · Parasite Immunology · doi:10.1111/pim.12080 · Cited by 17
Perona‐Wright, G., Lundie, R. J., Jenkins, S. J., Webb, L. M., Grencis, R. K., & MacDonald, A. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101642 · Cited by 18
“profibrotic (9, 10), IL-4 is protective and essential for host survival (11, 12).”
BackgroundZhou, L., Shi, M., Zhao, L., Lin, Z., Tang, Z., Sun, H., Chen, T., Lv, Z., Xu, J., Huang, Y., et al. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2228-z · Cited by 18
Appleby, L. J., Nausch, N., Heard, F., Erskine, L., Bourke, C. D., Midzi, N., Mduluza, T., Allen, J. E., & Mutapi, F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00051 · Cited by 18
“Chronic inflammation associated with schistosomiasis is a hallmark of pathology (8, 9), and experimental models suggest that tissue inflammation is largely CD4+ T helper (Th) 2 driven (10, 11).”
BackgroundSun, J., Wu, M., Wang, L., Wang, P., Xiao, T., Wang, S., & Liu, Q. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114321 · Cited by 18
Immunomodulation by helminths: Similar impact on type 1 and type 2 diabetes?
Surendar, J., Indulekha, K., Hoerauf, A. M., & Hübner, M. P. (2016) · Parasite Immunology · doi:10.1111/pim.12401 · Cited by 19
Mouse tail models of secondary lymphedema: fibrosis gradually worsens and is irreversible.
Zhou, C., Su, W., Han, H., Li, N., Ma, G., & Cui, L. (2020) · Europe PMC (PubMed Central) · Cited by 18
Lauder, A., Jolin, H. E., Smith, P., van den Berg, J. G., Jones, A., Wisden, W., Smith, K. G. C., Dasvarma, A., Fallon, P. G., & McKenzie, A. N. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.113 · Cited by 16
“A further possibility is that IL-13, which has been shown to regulate fibrosis (38, 39), may predispose to inappropriate collagen deposition in the ureter, resulting in obstruction.”
BackgroundHirata, M., Hara, T., Kage, M., Fukuma, T., & Sendo, F. (2002) · Parasite Immunology · doi:10.1046/j.1365-3024.2002.00491.x · Cited by 16
Sombetzki, M., Rabes, A., Bischofsberger, M., Winkelmann, F., Koslowski, N., Schulz, C., & Reisinger, E. C. (2019) · BioMed Research International · doi:10.1155/2019/1704238 · Cited by 16
“In addition, direct interference with the type 2 cytokine IL-13 by IL-13 inhibitor sIL-13R α 2-Fc leads to significant reduction of hepatic fibrosis in a mouse model of S. mansoni infection [25].”
Talaat, R. M., El-Bassiouny, A., Osman, A. M., Yossif, M., Charmy, R., & Al-Sherbiny, M. M. (2007) · Parasitology Research · doi:10.1007/s00436-007-0478-y · Cited by 15
“Chiaramonte et al. (1999) proposed that IL-4 play a redundant role in granuloma formation, which explains the ability of IL-4 deficient mice to form granulomas around eggs.”
Backgroundde Souza, R. D. P., Cardoso, L. S., Lopes, G. T. V., Almeida, M. C., Oliveira, R. R., Alcântara, L. M., Carvalho, E. M., & Araújo, M. I. (2012) · Journal of Parasitology Research · doi:10.1155/2012/394981 · Cited by 15
“mansoni chronic infection in mice and humans, and that this response is involved in the development of periportal fibrosis due to schistosomiasis [21, 33–35].”
BackgroundTNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditions
Lana, J. P., Martins, L. B., Oliveira, M. C., Garcia, Z. M., Yamada, L. T. P., Vieira, L. Q., Teixeira, M. M., & Ferreira, A. V. M. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0265 · Cited by 16
Shinozaki, S., Mashima, H., Ohnishi, H., & Sugano, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.078 · Cited by 15
Properties and Immune Function of Cardiac Fibroblasts
Furtado, M. B., & Hasham, M. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57613-8_3 · Cited by 15
IL-17A-producing γδ T cells promote liver pathology in acute murine schistosomiasis
Sun, L., Gong, W., Shen, Y., Liang, L., Zhang, X., Li, T., Chen, T. T., Hu, Y., & Cao, J. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04200-4 · Cited by 15
IL-4 inhibits vasoactive intestinal peptide production by macrophages
Metwali, A., Blum, A. M., Elliott, D. E., & Weinstock, J. V. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00491.2001 · Cited by 15
“These cytokines are critically important for induction of the Th2 phenotype characteristic of schistosome granulomas (1, 2, 20).”
BackgroundMacrophage Plasticity and Polarization
Galdiero, M. R., & Mantovani, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800196-7.00006-2 · Cited by 15
Hou, X., Yu, F., Man, S., Huang, D., Zhang, Y., Liu, M., Ren, C., & Shen, J. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2011.10.008 · Cited by 14
Santos, S. B., Porto, A. F., Muniz, A. L., de Jesus, A. R., & Carvalho, E. M. (2004) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762004000900022 · Cited by 14
“However, more recent date point to the importance of type-2 cytokines such as IL-4 and IL-13 in inducing fibrosis and the ability of IL-12 and IFN-γ to decrease it (Wynn et al. 1994, Chiaramonte et al. 1999b, Jankovic et al. 1999).”
BackgroundShainheit, M. G., Saraceno, R., Bazzone, L. E., Rutitzky, L. I., & Stadecker, M. J. (2007) · Infection and Immunity · doi:10.1128/iai.01053-06 · Cited by 14
“Because the evolving, chronic schistosome infection results in incremental liver fibrosis (15) and there is significantly less IFNproduction in WSX-1 / mice, we examined 24-week-infected WSX-1 / and BL/6 mice for possible differences in overall immunopathology and cytokine production, including production of IL-13, wh…”
BackgroundResultInfluentialImplication de l'interleukine 13 et de son récepteur dans la sclérodermie systémique
Granel, B., Chevillard, C., & Dessein, A. J. J. (2007) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2007.04.005 · Cited by 14
A Mutation inIL4RAIs Associated with the Degree of Pathology in Human TB Patients
Hölscher, C., Heitmann, L., Owusu‐Dabo, E., Horstmann, R. D., Meyer, C. G., Ehlers, S., & Thye, T. (2016) · Mediators of Inflammation · doi:10.1155/2016/4245028 · Cited by 13
“Nevertheless, IL-13-dependent responses can also develop in the absence of IL-4Rα-mediated signaling through the IL-13Rα2 chain [26], whichwas originally thought to operate exclusively as a decoy receptor for IL-13 [27, 28].”
BackgroundIsayama, F., Moore, S. M., Hines, I. N., & Wheeler, M. D. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.02.006 · Cited by 13
Parasites and immunotherapy: with or against?
Darani, H. Y., Yousefi, M., Safari, M., & Jafari, R. (2014) · Journal of Parasitic Diseases · doi:10.1007/s12639-014-0533-4 · Cited by 13
“Treatment with IL-13 inhibitor (sIL-13Ra2-Fc) remarkably reduces the formation of hepatic fibrosis in mice when infected by S. mansoni (Chiaramonte et al. 1999).”
BackgroundXu, Y., Lin, J., Bian, M., Chen, W., Liang, P., Wang, X., Shang, M., Qu, H., Wu, Z., Huang, Y., et al. (2015) · Parasitology Research · doi:10.1007/s00436-015-4435-x · Cited by 13
Autoimmune Hepatitis in Brazilian Children: IgE and Genetic Polymorphisms in Associated Genes
de Oliveira, L. C., Goldberg, A. C., Marin, M. L. C., Schneidwind, K. P. D. R., Frade, A. F., Kalil, J. E., Miura, I. K., Pugliese, R. P. S., Danesi, V. L. B., & Porta, G. (2015) · Journal of Immunology Research · doi:10.1155/2015/679813 · Cited by 13
“IL13, together with IL5 [18], is a potent mediator of tissue fibrosis and tissue remodeling, as shown in experimental models of schistosomiasis [19].”
BackgroundExperimental models of sarcoidosis
Jeny, F., Pachéco, Y., Besnard, V., Valeyre, D., & Bernaudin, J. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000295 · Cited by 13
“Blocking IL-13 reduced this fibrosis [77].”
Ndlovu, H., Nono, J. K., Aziz, N. A., Nieuwenhuizen, N. E., & Brombacher, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02928 · Cited by 13
Ghia, P., Strola, G., Granziero, L., Geuna, M., Guida, G., Sallusto, F., Ruffing, N., Montagna, L., Piccoli, P., Chilosi, M., et al. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200205)32:5<1403::aid-immu1403>3.0.co;2-y · Cited by 271
Role of cGAS-STING pathway in fibrotic disease
Feng, L., Zhang, F., Cao, J., & Xiong, W. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107971 · Cited by 15
Ferreira, D. S., Arora, G., Gieseck, R. L., Rotile, N. J., Waghorn, P. A., Tanabe, K. K., Wynn, T. A., Caravan, P. D., & Fuchs, B. C. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000737 · Cited by 13
“This model is nonresponsive to these profibrotic cytokines and instead presents with an enhanced proinflammatory cytokine response.(50) 4R-Delta mice imaged 20 minutes after EP-3533 injection demonstrated similar ΔR1 and ΔCNR values to the naive mice.”
BackgroundSelf-citationMagalhães, L., Nogueira, D. S., Gazzinelli-Guimarães, P. H., Oliveira, F. M. S., Kraemer, L. R., Gazzinelli-Guimarães, A. C., Vieira-Santos, F., Fujiwara, R. T., & Bueno, L. L. (2021) · Parasitology · doi:10.1017/s0031182021000627 · Cited by 16
“An IL-13 inhibitor was able to block the development of liver fibrosis in a murine model of schistosomiasis (Chiaramonte et al., 1999).”
BackgroundRayia, D. M. A., Ashour, D. S., Safia, H. S. A., Ghafar, M. T. A., Amer, R. S., & Saad, A. E. (2022) · Pathogens and Global Health · doi:10.1080/20477724.2022.2064795 · Cited by 13
“Interleukin 4 (IL4) and IL-13 are potent inducers of collagen production and fibroblast proliferation [54], while IL-10 has been associated with fibrosis regression [55].”
BackgroundSombetzki, M., Reinholdt, C., Winkelmann, F., Rabes, A., Koslowski, N., & Reisinger, E. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010932 · Cited by 12
Co-infections HTLV-1-Strongyloides stercoralis
Pays, J. F. (2011) · Bulletin de la Société de pathologie exotique · doi:10.1007/s13149-011-0175-z · Cited by 13
“Cette action bénéfique pourrait être mise au crédit de l’augmentation de la production d’IFNγ [83] soit directement, soit indirectement, par l’induction par cette dernière d’une diminution de la production d’IL-4 et d’IL-13, interleukines fortement impliquées dans le processus de fibrose [10,35].”
BackgroundChen, Q., Guan, F., Yan, D., Lei, D.-S., Fu, L., Xia, H. S., Zhu, Y. H., Chen, Z. W., & Anou, N. (2011) · Tissue Antigens · doi:10.1111/j.1399-0039.2011.01809.x · Cited by 12
“Detection of AIF-1 and TNF-α in the supernatant of splenic cell cultures by ELISA The total splenic cells from mice at weeks 5, 8 and 14 PI were cultured, respectively, in the presence of SEA at 37◦C with 5% CO2 for 72 h. AIF-1 and TNF-α concentrations were detected in the supernatant with ELISA.”
MethodInundation of asthma target research: Untangling asthma riddles
Singh, J., Shah, R., & Singh, D. (2016) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2016.09.010 · Cited by 13
Journey through Crohn’s Disease Complication: From Fistula Formation to Future Therapies
Rubbino, F., Greco, L., di Cristofaro, A., Gaiani, F., Vetrano, S., Laghi, L., Bonovas, S., & Piovani, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235548 · Cited by 13
Regulation of the Development of the Hepatic B Cell Compartment during Schistosoma mansoni Infection
Fairfax, K. C., Everts, B., Smith, A. M., & Pearce, E. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301357 · Cited by 14
Allam, G. A., & Abuelsaad, A. S. A. (2013) · Central European Journal of Immunology · doi:10.5114/ceji.2013.34355 · Cited by 12
TGF-β and IL-10 regulation of IFN-γ produced in Th2-type schistosome granulomas requires IL-12
Qadir, K., Metwali, A., Blum, A. M., Li, J., Elliott, D. E., & Weinstock, J. V. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.4.g940 · Cited by 14
Biochemical markers of postsurgical knee arthrofibrosis: A systematic review
Wyatt, P. B., Satalich, J. R., Cyrus, J. W. W., O’Neill, C. N., & O'Connell, R. (2022) · Journal of Orthopaedics · doi:10.1016/j.jor.2022.10.008 · Cited by 11
Bae, J., Kim, J. E., Perumalsamy, H., Park, S., Kim, Y., Jun, D. W., & Yoon, T. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.814030 · Cited by 12
Li, Y. S., ZENG, Q., Ellis, M. K., Xiong, T., Balen, J., & McManus, D. P. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.910 · Cited by 11
Zhong, Y., Xu, M., Hu, J., Huang, X., Lin, N., & Deng, M. (2021) · Aging · doi:10.18632/aging.202425 · Cited by 11
“T helper (Th) cells, particularly classical Th1 and Th2 cells, can profoundly influence the fibrotic response and dominate the development of liver fibrosis [8, 9].”
BackgroundGu, J., Liu, K., Liu, X., Wang, X., & Yang, K. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu021 · Cited by 11
“IL-13 and its receptors are regarded as dominant mediators in fibrosis [25,26].”
BackgroundNew approaches for fibrosis regression in alcoholic cirrhosis
Mehal, W. Z., & To, U. K. (2016) · Hepatology International · doi:10.1007/s12072-016-9752-3 · Cited by 13
“TH1 cells secrete IFN1 and IL12 cytokines that are fibrolytic whereas TH2 cells secrete IL4 and IL13 that are fibrogenic [13, 14].”
BackgroundEhlers, S., & Hölscher, C. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0116 · Cited by 11
IL-13 and TGF-β1: Core Mediators of Fibrosis
Borthwick, L. A., & Wynn, T. A. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0091-1 · Cited by 10
“Soluble IL-13Ra2-Fc is a highly effective inhibitor of IL-13 that has been shown to ameliorate the progression of established fibrotic disease [60, 78, 83, 84] suggesting that modulation of the IL-13 signalling pathway may be a viable therapeutic target for numerous fibrotic diseases [2].”
InfluentialSelf-citationCho, M., Park, J.-G., Iwata, H., & Kim, E.-Y. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.111947 · Cited by 10
Dutra, W. O., Corrêa‐Oliveira, R., Dunne, D. W., Cecchini, L. F., Fraga, L. A. D. O., Roberts, M., Silveira, A. M. S., Webster, M. L., Yssel, H., & Gollob, K. J. (2002) · BMC Immunology · doi:10.1186/1471-2172-3-8 · Cited by 10
Zhang, Y., Li, C., Zhang, M., & Li, Z. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.030 · Cited by 10
Profound effect of the absence of IL-4 on T cell responses during infection withSchistosoma mansoni
Pedras-Vasconcelos, J., Brunet, L. R., & Pearce, E. J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.5.737 · Cited by 10
“[4] and non-T cells [5, 6 ], and they are induced primarily by parasite egg antigen [7].”
BackgroundAllah, M. A., Zaalouk, T. K., Abo-Sheishaa, G. A., Shalash, I., & Bayoumy, A. (2022) · Egyptian journal of Immunology · doi:10.55133/eji.290417 · Cited by 9
de Morais, C. N. L., de Souza, J. R., Melo, W. G., Aroucha, M. L., Domingues, A. L. C., Wynn, T. A., Abath, F. G. C., & Montenegro, S. M. (2002) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762002000900023 · Cited by 9
“A distinct and most important function of IL-13, was the observation that IL13 and not IL-4 was the major type 2 cytokine driving type I and III collagen mRNA production and hepatic fibrosis in infected mice (Wynn et al. 1993, Chiaramonte et al. 1999).”
BackgroundSelf-citationEarly infiltration of p40IL12+CCR7+CD11b+cells is critical for fibrosis development
Braga, T. T., Corrêa-Costa, M., de Azevedo, H. F. Z., Silva, R. C., Cruz, M. C., de Almeida, M. E. S., Hiyane, M. I., Moreira‐Filho, C. A., dos Santos, M. F., Perez, K. R., et al. (2016) · Immunity Inflammation and Disease · doi:10.1002/iid3.114 · Cited by 9
Choto, E. T., Mduluza, T., & Chimbari, M. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252220 · Cited by 9
“High IL-13 is associated with the development of hepatic fibrosis [15,16] and periportal fibrosis [17].”
BackgroundThe Th1/Th2 Paradigm in Infections
Mosmann, T. R., & Fowell, D. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817978.ch12 · Cited by 9
Finger, E., Brodeur, P. H., Hernández, H. J., & Stadecker, M. J. (2005) · European Journal of Immunology · doi:10.1002/eji.200526344 · Cited by 9
Sánchez-Menéndez, C., Rodríguez-Pérez, J., Fuertes, D., Leguizamon, V., González-Sanmartin, M., Mateos, E., Cervero, M., José, E. S., Sanz, G., Álvaro, E., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1692382 · Cited by 10
Madala, S. K., Dolan, M. A., Sharma, D., Ramalingam, T. R., Wilson, M. S., Mentink‐Kane, M. M., Masison, D. C., & Wynn, T. A. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22881 · Cited by 9
Self-citationFibrosis in low-grade follicular lymphoma – a link to the TH2 immune reaction
Lohneis, P., Wienert, S., Klauschen, F., Anagnostopoulos, I., & Jöhrens, K. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1231404 · Cited by 8
Yu, M., Chen, P., Jin, Y., Huang, S., Jiang, H., Zhou, F., Chiu, M. L., & Zhang, D. (2025) · Cells · doi:10.3390/cells14221747 · Cited by 7
“A third receptor, IL-13R α 2, binds IL-13 with high affinity but generally lacks classical signaling capacity, functioning primarily as a decoy receptor that limits IL-13–driven inflammation [21].”
Fibrosis in the GI Tract: Pathophysiology, Diagnosis and Treatment Options
Pinzani, M. (2009) · Frontiers of gastrointestinal research · doi:10.1159/000258275 · Cited by 7
Abuelsaad, A. S. A. (2013) · Cited by 7
Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis
Tsukui, T., Shichino, S., Shimaoka, T., Ueha, S., & Matsushima, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-56068-5_2 · Cited by 7
Santana, J. B., de Almeida, T. V. V. S., Lopes, D. M., Page, B., Oliveira, S. C., Souza, I., Ribeiro, L. E., Guerrero, N. A., Carvalho, E. M., & Cardoso, L. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.605235 · Cited by 8
“Many studies have pointed to IL-13 as the main pro-fibrotic cytokine, since its blockade is capable of both preventing the onset of periportal fibrosis and of reducing already established fibrosis (17, 29, 30).”
BackgroundSaleki, K., Razi, S., & Rezaei, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818006-8.00007-4 · Cited by 7
Huang, J. S. W., Sheu, J. J., Wu, S. C. S., & Chang, T. W. (2002) · Immunology Letters · doi:10.1016/s0165-2478(01)00332-7 · Cited by 7
Role of Fibroblasts and Myofibroblasts in Idiopathic Pulmonary Fibrosis
Gharaee‐Kermani, M., & Phan, S. H. (2003) · CRC Press eBooks · doi:10.3109/9780203913444-24 · Cited by 7
Oshima, Y., & Puri, R. K. (2001) · The FASEB Journal · doi:10.1096/fj.00-0711fje · Cited by 8
“Several studies in the literature suggest that antagonizing effects of IL-13 provides therapeutic benefit in various murine inflammatory disease models, including bronchial asthma (8, 9), hepatic fibrosis induced by Schistosomiasis (10) and decreased in susceptibility to Leishmania”
BackgroundRathinam, S. R., Arya, L. K., Karthikeyan, R. S. G., & Sen, S. (2021) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2020.1855356 · Cited by 6
“Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni.(33) This suggests that IL-5 may function in the early facilitation of the production of the fibrotic cytokines IL-13 and/or TGF-β, which then carry forward the main effect of tissu…”
BackgroundChen, Q.-R., Guan, F., Song, S.-M., Jin, J.-K., Lei, D.-S., Chen, C., Lei, J., Chen, Z.-W., & Anou, N. (2014) · Parasitology Research · doi:10.1007/s00436-014-3915-8 · Cited by 6
IL-13 as Target to Reduce Cholestasis and Dysbiosis in Abcb4 Knockout Mice
Hahn, L., Helmrich, N., Herebıan, D., Mayatepek, E., Drebber, U., Domann, E., Olejniczak, S., Weigel, M., Hain, T., Räth, T., et al. (2020) · Cells · doi:10.3390/cells9091949 · Cited by 6
Park, H., Jo, S., & Jung, U. (2017) · Journal of Radiation Protection and Research · doi:10.14407/jrpr.2017.42.4.177 · Cited by 6
Yao, Y., Zhou, C., & Chu, D. (2014) · Experimental Parasitology · doi:10.1016/j.exppara.2014.04.004 · Cited by 6
Jiang, S., Feng, J., Jiang, Y., Lü, Z., Kong, J., Li, X., Lian, H., Zhang, F., Li, J., & Li, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111206 · Cited by 7
Alfred, M. O., Ochola, L. B., Okeyo, K. O., Bae, E., Ogongo, P., Odongo, D., Njaanake, K. H., & Robinson, J. P. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1521265 · Cited by 5
Adachi, K., Osada, Y., Nakamura, R., Tamada, K., & Hamano, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082698 · Cited by 8
Eosinophils in repair and remodelling
Kay, A. B., Flood-Page, P. T., Menzies-Gow, A. N., Robinson, D. S., & Phipps, S. (2004) · Clinical & Experimental Allergy Reviews · doi:10.1111/j.1472-9725.2004.00059.x · Cited by 5
Interactions of Stellate Cells with Other Non-Parenchymal Cells
Kawada, N., & Parola, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00012-9 · Cited by 8
Ndlovu, H., Nono, J. K., Nieuwenhuizen, N. E., & Brombacher, F. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.ma0318-115r · Cited by 5
Protective Effect of S-Allyl Cysteine Against Neonatal Asthmatic Rats
Jiang, L., Li, Y., Wang, F., Zhang, X., & Zhao, R. (2020) · Dose-Response · doi:10.1177/1559325820982189 · Cited by 5
Atsukawa, K., Saito, H., Tsukada, N., Akiba, Y., Toda, K., Kumagai, N., Ohishi, T., Kamegaya, Y., & Ishii, H. (2001) · Hepatology Research · doi:10.1016/s1386-6346(00)00133-9 · Cited by 5
Novel perspectives on the origins of the hepatic myofibroblasts
Kisseleva, T., Xu, J., Liu, X., & Brenner, D. A. (2015) · Cell Health and Cytoskeleton · doi:10.2147/chc.s57679 · Cited by 5
Formalpathogenese der tuberkul�sen Gewebsver�nderungen
Ehlers, S. (2003) · Der Internist · doi:10.1007/s00108-003-1036-z · Cited by 5
Cytokine Phenotypes and the Progression of Chronic Pulmonary Fibrosis
Kunkel, S. L., Lukacs, N. W., Chensue, S. W., & Hogaboam, C. M. (2003) · Lung biology in health and disease · doi:10.1201/b14211-12 · Cited by 5
Immune cells in liver regeneration: Current evidence and potential clinical targets
Moore, H. F., Usmani, S., Froghi, S., Rashidi, H., Quaglia, A., Fuller, B. J., & Davidson, B. R. (2025) · International Reviews of Immunology · doi:10.1080/08830185.2025.2531820 · Cited by 5
“…of fibrotic tissue, followed by ECM remodeling and resolution of fibrosis, which IL-4 and IL-13 contribute to by promoting HSC activation and collagen deposition [364–368], TGF-β activation [365,368,369], cholangiocyte and HPC proliferation [78] and M2 macrophage differentiation [370–372].”
Pericytes and T Cells in Lung Injury and Fibroproliferation
Birbrair, A., Prazeres, P. H. D. M., Files, D. C., & Delbono, O. (2018) · Molecular and translational medicine · doi:10.1007/978-3-319-98143-7_7 · Cited by 4
Enhancing Regulatory T cell function by mevalonate pathway inhibition prevents liver fibrosis
Bae, A.-N., Lee, H., Yang, H., Mukherjee, S., Im, S., Lee, J., & Park, J. H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151094 · Cited by 4
Yang, L., Sun, L., Cao, Y., Wang, Q., Song, A., Zhu, R., Liu, W., & Lu, S. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s354224 · Cited by 4
“Evidence both from patient and from mouse model indicates that IL-13 is a strong accelerator for the progress of liver fibrosis after Schistosoma infection.(13,14) IL-4, IL-10 and IL-13 can also stimulate macrophage transformation into alternatively activated macrophages, which are a major source found in inflammatory…”
Background
Metadata
- Authors
- Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 777-785
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408441
- OpenAlex
- W1975021657
- Cited by
- 603
- References
- 47
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 7 · 2023: 8 · 2022: 14 · 2021: 16 · 2020: 21 · 2019: 13 · 2018: 34 · 2017: 18 · 2016: 30 · 2015: 28 · 2014: 35 · 2013: 23 · 2012: 30
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-13, liver fibrosis, schistosomiasis, Schistosoma mansoni, Th2 cytokines, IL-4, granuloma formation, collagen synthesis, fibroblasts, procollagen mRNA, antifibrotic therapy
- MeSH terms
- Animals, Female, Liver, Liver Cirrhosis, Experimental, Mice, Inbred C57BL, Procollagen, RNA, Messenger, Schistosomiasis mansoni, Interleukin-4, Cytokines, 3T3 Cells, Mice, Knockout, Th1 Cells, Th2 Cells, Interleukin-13, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.